Identifying Adverse Events in Outpatients With Prostate Cancer Using Pharmaceutical Care Records in Community Pharmacies: Application of Named Entity Recognition
BackgroundAndrogen receptor axis-targeting reagents (ARATs) have become key drugs for patients with castration-resistant prostate cancer (CRPC). ARATs are taken long term in outpatient settings, and effective adverse event (AE) monitoring can help prolong treatment duration f...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
JMIR Publications
2025-03-01
|
| Serier: | JMIR Cancer |
| Online adgang: | https://cancer.jmir.org/2025/1/e69663 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
